New Lyme Disease Vaccine Shows Strong Results in Trial
via HealthDayTUESDAY, March 24, 2026 — A new vaccine meant to prevent Lyme disease may be one step closer to approval.
Drugmaker Pfizer and French vaccine company Valneva said their vaccine, called LB6V, worked more than 70% of the time in a clinical trial to prevent Lyme disease in people ages 5 and older.
The companies also said the vaccine was well tolerated, with no safety concerns identified.
“These results bring us a step closer to our goal of delivering a much-needed vaccine to help protect against Lyme disease,” Thomas Lingelbach, Valneva’s chief executive, told The Wall Street Journal.
Pfizer said the vaccine showed clear benefits.
The trial took longer than expected, because a pre-determined statistical target wasn’t met by the initial deadline.
The company noted that the target was met in a second planned analysis, and that the level of protection seen in the study was meaningful.
Based on these findings, Pfizer said it plans to move forward with submissions to regulatory authorities.
Lyme disease is caused by bacteria that's spread through the bite of infected ticks.
Early symptoms can include:
Because these symptoms can be mild or mistaken for other illnesses, the disease is sometimes missed early on.
Left untreated, Lyme disease can lead to more serious problems affecting the joints, heart or the nervous system, the Cleveland Clinic says.
There is no currently approved vaccine for Lyme disease in humans, making LB6V the most advanced option yet, according to the pharmaceutical companies.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-03-25 01:58
Read more
- Prenatal Valproate Exposure Tied to Offspring Neurodevelopmental Risks
- About 3,000 Wayfair Dressers Recalled Over Child Tip-Over Risk
- FDA Approves Icotyde (icotrokinra) for the Treatment of Plaque Psoriasis
- Novo Nordisk Announces Significant Reduction in US List Price for Wegovy, Ozempic, and Rybelsus (semaglutide medicines), Building on Continued Efforts to Expand Access
- Inflammation Linked To Brain Damage, Memory Problems Among Football Players
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions